"Forging an Innovation Ecosystem, Pioneering a New Era in Pharmaceuticals — SAPA-China 2025 Pharmaceutical Industry Conference" will be held from October 31 to November 1, 2025, at the Suzhou Shishan International Convention Center. Over 8,000 leading experts and scholars from top global research institutions, as well as industry leaders from multinational pharmaceutical and biotech companies, will gather to focus on cutting-edge fields such as innovative large/small molecule drugs, cell/gene therapies, AI-driven drug development, nucleic acid drugs, advanced and innovative formulations, GLP-1 and metabolism, synthetic biology, clinical research, ophthalmology, medical aesthetics, outbound collaboration, investment, and financing. The conference will feature keynote speeches, panel discussions, corporate exhibitions, and one-on-one business matchmaking to foster comprehensive exchange and cooperation. This event serves as both an international academic platform connecting the entire pharmaceutical industry chain and a premier bridge for capital-project and global collaboration opportunities.

JOINN will participate in this grand event (Booth No. T23). Additionally, Yang Mei, Head of the Molecular Biology Department at Signpost (Beijing) Testing Technology Co., Ltd., will deliver a keynote speech titled "Development and Application of Clinical Trial Bioanalysis Key Technologies for in vivo CAR-T Drugs" at the Translational Medicine Forum. We sincerely invite industry experts, scholars, and peers to attend, engage in in-depth discussions, and explore future collaboration possibilities together!